Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Breast Neoplasms × Dipeptidyl-Peptidase IV Inhibitors × 1 year × Clear all

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Pulmonary Disease, Chronic Obstructive 1 Lung Neoplasms 1 Disease 1 Diabetes Mellitus, Type 2 1 Colorectal Neoplasms 1 Breast Neoplasms 1

Interventions

Fulvestrant 116 Trastuzumab 101 Letrozole 100 Paclitaxel 96 pembrolizumab 70 Capecitabine 65 Anastrozole 63 palbociclib 62 abemaciclib 60 Cyclophosphamide 60 pertuzumab 58 Carboplatin 55 exemestane 53 Tamoxifen 53 ribociclib 52 trastuzumab deruxtecan 51 Radiotherapy 47 Docetaxel 47 Magnetic Resonance Spectroscopy 46 Surveys and Questionnaires 43 Specimen Handling 43 Blood Specimen Collection 37 olaparib 35 Standard of Care 29 Biopsy 29 sacituzumab govitecan 28 Exercise 27 Doxorubicin 27 130-nm albumin-bound paclitaxel 27 eribulin 24

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07436663 2026-02-27

SGLT2i/DPPi

Tanta University

Phase 4 Not yet recruiting

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡